The classes are designed to be inclusive in order to help people at all stages of the disease.
Trending
- Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy
- Pediatric Cancer Guide: Types, Early Signs, Treatment & Prognosis
- Novel Myelofibrosis Drug is “Versatile” for Managing Anemia
- Developing neoantigen cancer vaccines: where are we now?
- What Needs to Happen Before Menin Inhibitors Move Into Frontline AML Combinations?
- Early Camizestrant Is Favored Upon ESR1 Mutation Emergence in Breast Cancer
- Dabogratinib Shows Early Activity in FGFR3-Altered Low-Grade NMIBC
- Clinical translation of senescence-related pan-cancer multi-omics: tools for assessment and immunotherapy prediction

